These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 16942876

  • 1. 4'-Alkoxyl substitution enhancing the anti-mitotic effect of 5-(3',4',5'-substituted)anilino-4-hydroxy-8-nitroquinazolines as a novel class of anti-microtubule agents.
    Jin Y, Zhou ZY, Tian W, Yu Q, Long YQ.
    Bioorg Med Chem Lett; 2006 Nov 15; 16(22):5864-9. PubMed ID: 16942876
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and antitumor evaluation of novel 5-substituted-4-hydroxy-8-nitroquinazolines as EGFR signaling-targeted inhibitors.
    Jin Y, Li HY, Lin LP, Tan J, Ding J, Luo X, Long YQ.
    Bioorg Med Chem; 2005 Oct 01; 13(19):5613-22. PubMed ID: 15993078
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and antiproliferative evaluation of certain 4-anilino-8-methoxy-2-phenylquinoline and 4-anilino-8-hydroxy-2-phenylquinoline derivatives.
    Chen YL, Huang CJ, Huang ZY, Tseng CH, Chang FS, Yang SH, Lin SR, Tzeng CC.
    Bioorg Med Chem; 2006 May 01; 14(9):3098-105. PubMed ID: 16412647
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 7-Diethylamino-3(2'-benzoxazolyl)-coumarin is a novel microtubule inhibitor with antimitotic activity in multidrug resistant cancer cells.
    Kim SN, Kim NH, Park YS, Kim H, Lee S, Wang Q, Kim YK.
    Biochem Pharmacol; 2009 Jun 15; 77(12):1773-9. PubMed ID: 19428332
    [Abstract] [Full Text] [Related]

  • 6. A novel isocoumarin derivative induces mitotic phase arrest and apoptosis of human multiple myeloma cells.
    Kawano T, Agata N, Kharbanda S, Avigan D, Kufe D.
    Cancer Chemother Pharmacol; 2007 Feb 15; 59(3):329-35. PubMed ID: 16830153
    [Abstract] [Full Text] [Related]

  • 7. Microtubule-damaging agents enhance RASSF1A-induced cell death in lung cancer cell lines.
    Whang YM, Park KH, Jung HY, Jo UH, Kim YH.
    Cancer; 2009 Mar 15; 115(6):1253-66. PubMed ID: 19156899
    [Abstract] [Full Text] [Related]

  • 8. Phenylcinnamides as novel antimitotic agents.
    Leslie BJ, Holaday CR, Nguyen T, Hergenrother PJ.
    J Med Chem; 2010 May 27; 53(10):3964-72. PubMed ID: 20411988
    [Abstract] [Full Text] [Related]

  • 9. Novel, potent and selective anilinoquinazoline and anilinopyrimidine inhibitors of p38 MAP kinase.
    Cumming JG, McKenzie CL, Bowden SG, Campbell D, Masters DJ, Breed J, Jewsbury PJ.
    Bioorg Med Chem Lett; 2004 Nov 01; 14(21):5389-94. PubMed ID: 15454232
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives.
    Ali MA, Shaharyar M, Siddiqui AA.
    Eur J Med Chem; 2007 Feb 01; 42(2):268-75. PubMed ID: 17007966
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and biological evaluation of substituted 6-alkynyl-4-anilinoquinazoline derivatives as potent EGFR inhibitors.
    Liu LT, Yuan TT, Liu HH, Chen SF, Wu YT.
    Bioorg Med Chem Lett; 2007 Nov 15; 17(22):6373-7. PubMed ID: 17889528
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis of a new class of 2-anilino substituted nicotinyl arylsulfonylhydrazides as potential anticancer and antibacterial agents.
    Kamal A, Khan MN, Srinivasa Reddy K, Rohini K.
    Bioorg Med Chem; 2007 Jan 15; 15(2):1004-13. PubMed ID: 17097292
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synthesis and in vitro antiplasmodial evaluation of 4-anilino-2-trichloromethylquinazolines.
    Verhaeghe P, Azas N, Hutter S, Castera-Ducros C, Laget M, Dumètre A, Gasquet M, Reboul JP, Rault S, Rathelot P, Vanelle P.
    Bioorg Med Chem; 2009 Jul 01; 17(13):4313-22. PubMed ID: 19482476
    [Abstract] [Full Text] [Related]

  • 17. Cellular analysis of disorazole C and structure-activity relationship of analogs of the natural product.
    Wipf P, Graham TH, Vogt A, Sikorski RP, Ducruet AP, Lazo JS.
    Chem Biol Drug Des; 2006 Jan 01; 67(1):66-73. PubMed ID: 16492150
    [Abstract] [Full Text] [Related]

  • 18. Benzoylurea derivatives as a novel class of antimitotic agents: synthesis, anticancer activity, and structure-activity relationships.
    Song DQ, Wang Y, Wu LZ, Yang P, Wang YM, Gao LM, Li Y, Qu JR, Wang YH, Li YH, Du NN, Han YX, Zhang ZP, Jiang JD.
    J Med Chem; 2008 Jun 12; 51(11):3094-103. PubMed ID: 18457382
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 4'-methoxy-2-styrylchromone a novel microtubule-stabilizing antimitotic agent.
    Marinho J, Pedro M, Pinto DC, Silva AM, Cavaleiro JA, Sunkel CE, Nascimento MS.
    Biochem Pharmacol; 2008 Feb 15; 75(4):826-35. PubMed ID: 18036572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.